Bipolar disorder: current treatments and new strategies.
Sachs
G S
GS
Massachusetts General Hospital, Boston 02114, USA.
Cosgrove
V E
VE
D000085:Acetates / Q000627:therapeutic use; D000588:Amines; D000927:Anticonvulsants / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D003509:Cyclohexanecarboxylic Acids; D005632:Fructose / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077206:Gabapentin; D006801:Humans; D000077213:Lamotrigine; D008094:Lithium / Q000627:therapeutic use; D019964:Mood Disorders / Q000188:drug therapy / Q000517:prevention & control; D000077236:Topiramate; D016896:Treatment Outcome; D016312:Treatment Refusal; D014227:Triazines / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D014227:Triazines; D000077236:Topiramate; D005632:Fructose; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D008094:Lithium; D000077213:Lamotrigine